N2 Jenomics Lab Pvt. Ltd. offers research-grade HLA typing services, utilizing Sanger sequencing, NGS, and Long-read sequencing technologies to precisely analyze HLA gene polymorphisms, supporting immunogenetics and disease mechanism research.
N2 Jenomics Lab Pvt. Ltd. offers research-grade HLA typing services, utilizing Sanger sequencing, NGS, and long-read sequencing to precisely analyze HLA polymorphisms. We now also provide integrated KIR typing services, covering the complete gene family (14 genes + 2 pseudogenes) with haplotype-level CNV and allele resolution. The combined workflow delivers >99% accuracy for both HLA & KIR typing from the same ≥1 μg DNA input, supporting comprehensive immunogenetics and disease mechanism research.
HLA typing is a laboratory technique used to identify the specific versions (alleles) of HLA genes a person carries. Located on chromosome 6, these genes encode Major Histocompatibility Complex (MHC) proteins, which play a pivotal role in the immune system. By analyzing polymorphisms in these genes, scientists can determine an individual's HLA type. This information is valuable for transplantation research and for studies of disease associations.
Our HLA typing focuses on the classes that encode HLA molecules:
Note: Class III genes are involved in immune signaling (e.g., complement proteins, cytokines), but do not encode HLA molecules and are not covered in our typing service.

The MHC locus is located on the short arm of human Chromosome 6 with some of the HLA genes indicated. (Wassenaar, Trudy M., et al., 2024)
Our high-resolution HLA typing services support a wide range of research areas that rely on understanding immune genetics. Below are some of the key fields where accurate HLA data makes a critical difference:

1
Population Genetics & Diversity Analysis
Study allele distribution across different populations to uncover patterns in genetic diversity and immune response variability.
2
Immunogenetics & TCR/BCR Studies
Combine HLA typing with TCR/BCR sequencing to explore antigen recognition and immune system interactions at a deeper level.
3
Immune Response Profiling
Investigate how HLA variations contribute to individual differences in immune activity, informing biomarker discovery and immune modeling.
4
Antigen Discovery & Vaccine Development
Utilize HLA data to predict antigen presentation pathways, supporting research in immunogen design and peptide screening.
5
Reference Panel & Database Construction
Build reliable population reference datasets for downstream association studies or large-scale genomic research.
At N2 Jenomics Lab Pvt. Ltd. , we provide multiple HLA typing solutions optimized for different research needs. Whether you're working with large sample sets, targeting rare alleles, or require ultra-high resolution, we offer flexible platforms to support your project.
| Typing Technology | Core Advantages | Supported Loci | Ideal For |
|---|---|---|---|
| Sanger Sequencing (SBT) | - Classic method with clear results - Highly versatile | HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQB1, HLA-DPB1 (6 loci) | - Projects with defined targets - Moderate sample sizes - Routine research needs |
| Next-Generation Sequencing (NGS) | - High throughput and resolution - Supports automation - Flexible locus selection | Option for 6 or 11 loci, including HLA-DQA1, HLA-DPA1 | - Large sample volumes - High diversity requirements - Broad locus coverage - Rapid analysis |
| Long-Read Sequencing (PacBio) | - Full-length HLA reads - Eliminates ambiguities - Identifies rare/novel alleles | Comprehensive coverage of the entire HLA gene range (11 loci and more) | - Research requiring exceptional accuracy - High-resolution typing of complex samples |
| Nanopore Sequencing (NanoTYPE) | - Fast and efficient - Single-tube multiplex PCR - Specialized software support | HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DQA1, HLA-DQB1, HLA-DPA1, HLA-DPB1, HLA-DRB3/4/5 (11 loci) | - Projects needing rapid results - Efficient processing with comprehensive locus coverage |
Building on our high-resolution HLA profiling, N2 Jenomics Lab Pvt. Ltd. now offers precision KIR typing, covering all 14 canonical KIR genes and 2 pseudogenes. Our workflow enables both allele-level resolution and gene copy number variation (CNV) detection, providing comprehensive insights into KIR diversity.
Core Features
Technical Advantages
| Feature | Value |
|---|---|
| Complete KIR panel | 14 loci + 2 pseudogenes, including highly polymorphic and duplicated genes |
| Allele & CNV-level resolution | Up to 7-digit typing via NGS or long-read sequencing |
| Unified workflow | Same input (≥ 1 µg DNA) and pipeline as HLA typing |
| High accuracy | >99% at gene level, >98% allele concordance across validations |
Recommended Applications
When precision matters in HLA typing, a reliable and thorough process is essential. At N2 Jenomics Lab Pvt. Ltd. , we’ve developed a meticulous workflow that covers every step—from sample extraction to data analysis—to deliver accurate HLA typing reports tailored to your research needs.

Note: The IMGT/HLA database we use is the WHO-recommended gold standard for HLA typing.
Detection Range:
| HLA Genotype | Detection Range |
|---|---|
| Single Genotype (Classical Class I and II) | HLA-A, B, C, DRB1, DQB1, DPB1 and non-classical loci HLA-E, HLA-G (Sanger sequencing) |
| 6 Genotypes (Classical Class I and II) | HLA-A, B, C, DRB1, DQB1, DPB1 and non-classical loci HLA-E, HLA-G (Next-generation sequencing) |
| 15 Genotypes | HLA-A, B, C, DRB1, DQA1, DQB1, DPA1, DPB1, DRB3, DRB4, DRB5, DOA, DOB, DMA, DMB (Next-generation sequencing) |
| For additional HLA genotyping needs, please contact the project manager. | |
At N2 Jenomics Lab Pvt. Ltd. , we offer a range of tailored bioinformatics analyses to support your HLA typing needs:

| Sample Type | Sample Volume |
|---|---|
| Whole Blood | ≥2 mL |
| Peripheral Blood | 3~5 mL; EDTA anticoagulant (purple cap) or sodium citrate anticoagulant (blue cap) |
| Cells | ≥10^6 |
| DNA | ≥1 μg, ≥30 ng/μl |
| RNA | ≥1 μg, >80 ng/μl |
| Frozen Tissue | ≥10 mg |
| FFPE | ≥10 slides |
In the dynamic world of immunogenetic research, precision and reliability are key. N2 Jenomics Lab Pvt. Ltd. offers top-tier HLA typing solutions, empowering researchers with deep insights. With extensive experience in molecular biology and genomic sequencing, we ensure quality through integrated platforms and efficient operations.
At N2 Jenomics Lab Pvt. Ltd. , we’re committed to supporting your breakthroughs in immunogenetic research with dependable and mature services. Let us be your trusted partner in advancing scientific discovery.
HLA Typing: Key Types, Testing Methods, and Transplant Significance
Our HLA typing service provides high-resolution data tailored to support diverse research applications. Here's a quick overview of how to interpret the results.

We offer multiple resolution levels depending on the granularity needed:
HLA allele names follow the format: Gene*XX:XX (up to four fields)
Common symbols:
Reference
![]() Table of HLA Type Details (Mayor NP et al., PLoS One. 2015) | ![]() Distribution of HLA Allelic Presentation (Nguyen A et al., Journal of virology, 2020) | ![]() Distribution of Allelic Presentation for All HLA Alleles and Individually for HLA-A, HLA-B, and HLA-C (Nguyen A et al., Journal of virology, 2020) |
1. What information can be obtained through HLA gene sequencing and information analysis?
Through NGS, HLA typing enables precise identification of specific allele information at each HLA locus, distinguishing between classical and non-classical HLA genes. It also determines specific combinations of HLA allele groups inherited together on a single chromosome. Additionally, NGS-based methods detect previously unreported alleles and ascertain whether each HLA locus is homozygous or heterozygous.
NGS-based HLA typing methods offer advantages of high accuracy, resolution, throughput, and cost-effectiveness. However, the accuracy of NGS-based HLA typing heavily depends on bioinformatics analysis methods, showing significant variability among different approaches.
2. What are the main methods of genotyping?
Serological typing: Focused on the specificity of HLA antigens, this method mainly employs HLA microcytotoxicity tests to analyze HLA types. Serological methods are vital for determining HLA typing and serve as the internationally recognized standard technique.
DNA typing: Concentrating on the analysis of genes themselves, this approach encompasses two main methods: those based on nucleic acid sequence identification and those based on sequence molecular configuration. The nucleic acid sequence identification methods primarily include PCR-RFLP, PCR-SSO, PCR-SSP, PCR-SBT, and the recently emerging next-generation sequencing methods.
3. Is NGS-based HLA typing suitable for clinical applications?
Indeed, NGS-based HLA typing is increasingly being integrated into clinical practice, particularly for organ transplantation, disease association studies, and pharmacogenomics. Its capability to provide high-resolution and precise allele determination enhances compatibility assessments and supports the development of individualized therapeutic strategies.
4. What level of precision is typically required in genotyping?
The specificity of the genotyping should ideally meet the criteria set by the recording of HLA types in the IMGT/HLA database. Differences in the four-digit typing correspond to variations in the encoded proteins, which generally fulfill the demands of scientific research. However, for studies necessitating higher accuracy or specific cases in transplant matching, a six-digit typing may be necessary to acquire more detailed allelic information.
Customer Publication Highlight
The HLA class I immunopeptidomes of AAV capsid proteins
Journal: Frontiers in Immunology
Impact Factor: 8.786 (2022)
Published: 16 August 2023
Background
Adeno-associated viruses (AAVs) are widely used in gene delivery but face challenges due to immune responses against their capsid proteins. CD8+ T cells recognize HLA class I-presented peptides, but the natural repertoire of AAV capsid-derived peptides remains poorly characterized. This study aimed to identify the HLA class I immunopeptidomes of AAV2, AAV6, and AAV9 using mRNA-transfected monocyte-derived dendritic cells (MDDCs) and mass spectrometry. The goal was to map naturally processed peptides, assess cross-reactivity among serotypes, and refine immunogenicity risk assessment for gene delivery systems.
Materials & Methods
Sample Preparation
Sequencing
Data Analysis
Results
Table 1 Donor HLA alleles and frequencies in the US population.


The HLA class I immunopeptidomes of AAV serotypes.
Table 2 Naturally processed HLA class I peptides and their match with previous identified epitopes.


Eleven HLA class I peptides are highly conserved among AAV2, AAV6 and AAV9.

More than 60% of the AAV HLA class I peptides are contained within HLA class II clusters.
Conclusion
This study provides the first comprehensive analysis of HLA class I immunopeptidomes for AAV capsids, identifying 65 peptides (59 novel) and highlighting conserved regions with cross-reactivity potential. These findings enhance understanding of AAV-specific CD8+ T cell responses and inform strategies to mitigate immunogenicity in gene delivery systems. Future work should validate the immunogenicity of newly identified peptides and assess cross-presentation mechanisms in experimental models.
Reference